Pacira | PCRX - Ebitda





Ebitda تغيير تاريخ
Astellas Pharma JPY 183.68B 31.98B 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cara Therapeutics USD -2.39M 3.16M 2025-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 9.52B 389M 2025-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Novo Nordisk DKK 37.3B 5.86B 2025-12
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12
Xoma USD 2.52M 7.98M 2024-06
Zoetis USD 1.04B 87M 2025-09